Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9032)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World J Diabetes 2014; 5(1): 52-58 [PMID: 24567801 DOI: 10.4239/wjd.v5.i1.52] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i1/52.htm |
| Number | Citing Articles |
| 1 |
Vincenza Frisardi. Commentary: Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?. Frontiers in Public Health 2020; 8 doi: 10.3389/fpubh.2020.00351
|
| 2 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3): 326 doi: 10.3390/pathophysiology29030024
|
| 3 |
Che C. Colpitts, Hussein El-Saghire, Nathalie Pochet, Catherine Schuster, Thomas F. Baumert. High-throughput approaches to unravel hepatitis C virus-host interactions. Virus Research 2016; 218: 18 doi: 10.1016/j.virusres.2015.09.013
|
| 4 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10): 453 doi: 10.1111/1348-0421.13023
|
| 5 |
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection. Biology 2022; 12(1): 23 doi: 10.3390/biology12010023
|
| 6 |
Yasuhiro Matsue, Mikihiro Tsutsumi, Nobuhiko Hayashi, Takashi Saito, Mutsumi Tsuchishima, Nobuyuki Toshikuni, Tomiyasu Arisawa, Joseph George, Ratna B. Ray. Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection. PLOS ONE 2015; 10(3): e0118744 doi: 10.1371/journal.pone.0118744
|
| 7 |
So Mi Kim, Il Han Song. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. The Korean Journal of Internal Medicine 2018; 33(4): 670 doi: 10.3904/kjim.2018.202
|
| 8 |
Juli Bai, Feng Liu. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. Diabetes 2019; 68(6): 1099 doi: 10.2337/dbi18-0052
|
| 9 |
Mahmoud M. Elnokeety, Rasha Ahmed Darwish, Mohamed Tharwat Hegazy, Sameh Abouzeid, Ahmed Fayed. The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort. Renal Replacement Therapy 2023; 9(1) doi: 10.1186/s41100-023-00500-4
|
| 10 |
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis C. Acta Tropica 2018; 178: 258 doi: 10.1016/j.actatropica.2017.12.004
|
| 11 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1): 40 doi: 10.2337/cd18-0112
|
| 12 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Resistencia a la insulina en pacientes egipcios no diabéticos infectados con el virus de hepatitis C crónica. Revista de Gastroenterología de México 2020; 85(2): 173 doi: 10.1016/j.rgmx.2019.05.005
|
| 13 |
Ahmed S. Yousef, Alaliaa M. Sallam, Nahla S. kotb, Hala O. El-Mesallamy. The association of Fat Mass and Obesity-Associated (FTO) gene polymorphism (rs9939609) with metabolic disturbances and response to sofosbuvir, ribavirin and interferon triple therapy in patients with viral hepatitis C. Meta Gene 2021; 28: 100888 doi: 10.1016/j.mgene.2021.100888
|
| 14 |
Roy Hall, Leigh Owens, Brenda Govan, Marie Caltabiano, Paula Clancy, Alanna Sorenson, Yvonne Cadet-James. The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous Australians. The American Journal of Tropical Medicine and Hygiene 2016; 95(2): 265 doi: 10.4269/ajtmh.15-0727
|
| 15 |
EL Shaimaa Gomaa Ali, Rasha H. Bassyouni, Omayma O. Abdelaleem, Essam A. Hassan, Sylvana N. Gaber. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients. Virus Research 2022; 310: 198684 doi: 10.1016/j.virusres.2022.198684
|
| 16 |
N. K. T. Hlaing, R. A. Mitrani, S. T. Aung, W. W. Phyo, M. Serper, A. M. M. Kyaw, A. H. Bwa, K. M. Win, K. R. Reddy. Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotypes 1‐4 and 6 in Myanmar: Real‐world experience. Journal of Viral Hepatitis 2017; 24(11): 927 doi: 10.1111/jvh.12721
|
| 17 |
Geneviève F. Desrochers, Allison R. Sherratt, David R. Blais, Neda Nasheri, Zhibin Ning, Daniel Figeys, Natalie K. Goto, John Paul Pezacki. Profiling Kinase Activity during Hepatitis C Virus Replication Using a Wortmannin Probe. ACS Infectious Diseases 2015; 1(9): 443 doi: 10.1021/acsinfecdis.5b00083
|
| 18 |
Ayman Alsebaey, Mostafa Elhelbawy. Insulin resistance is not a risk factor for oesophageal varices development in hepatitis C. Tropical Doctor 2019; 49(4): 281 doi: 10.1177/0049475519863231
|
| 19 |
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis C. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(5): 420 doi: 10.1097/MCO.0000000000000396
|
| 20 |
Saeeda Fouzia Qasim, Ajmaal Jami, Paras Imran, Romana Mushtaque, Rashid Naseem Khan. Frequency of Metabolic Syndrome in Chronic Hepatitis C Patients: Findings From a Lower Middle Income Country. Cureus 2020; doi: 10.7759/cureus.11975
|
| 21 |
Gantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Yi-Hung Lin, Tzu-Chun Lin, Po-Cheng Liang, Ta-Wei Liu, Jia-Jung Lee, Yi-Ching Lin, I-Ling Lin, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Hung-Pin Tu, Chia-Yen Dai. The association between hepatitis C virus infection and renal function. Journal of the Chinese Medical Association 2021; 84(8): 757 doi: 10.1097/JCMA.0000000000000561
|
| 22 |
Yuki Haga, Tatsuo Kanda, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Osamu Yokosuka. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World Journal of Gastroenterology 2015; 21(46): 12989-12995 doi: 10.3748/wjg.v21.i46.12989
|
| 23 |
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4. Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
|
| 24 |
Diego García-Compeán, Emanuela Orsi, Ramesh Kumar, Felix Gundling, Tsutomu Nishida, Jesús Zacarías Villarreal-Pérez, Ángel N Del Cueto-Aguilera, José A González-González, Giuseppe Pugliese. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World Journal of Gastroenterology 2022; 28(8): 775-793 doi: 10.3748/wjg.v28.i8.775
|
| 25 |
Ammon Handisurya, Corinna Kerscher, Andrea Tura, Harald Herkner, Berit Anna Payer, Mattias Mandorfer, Johannes Werzowa, Wolfgang Winnicki, Thomas Reiberger, Alexandra Kautzky-Willer, Giovanni Pacini, Marcus Säemann, Alice Schmidt, Jose Ignacio Herrero. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. PLOS ONE 2016; 11(1): e0145319 doi: 10.1371/journal.pone.0145319
|
| 26 |
Pin-Nan Cheng, Hung-Yu Sun, I-Che Feng, Yen-Cheng Chiu, Sin-Tian Wang, Dyoness Charmaine Tan, Hung-Chih Chiu, Shih-Chih Chien, Kung-Chia Young. Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents. Journal of Microbiology, Immunology and Infection 2023; 56(1): 20 doi: 10.1016/j.jmii.2022.06.004
|
| 27 |
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantation. Journal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
|
| 28 |
Felix Gundling. Der hepatogene Diabetes – aktueller Stand der Diagnostik und Therapie. Journal für Klinische Endokrinologie und Stoffwechsel 2022; 15(2): 42 doi: 10.1007/s41969-022-00158-z
|
| 29 |
Wael A H Hegazy, Azza A H Rajab, Amr S Abu Lila, Hisham A Abbas. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World Journal of Diabetes 2021; 12(11): 1832-1855 doi: 10.4239/wjd.v12.i11.1832
|
| 30 |
Mohamed Salama, Manal Nomir, Maryan Fahmi, Amal El-Gayar, Mamdouh El-Shishtawy. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Scientia Pharmaceutica 2018; 86(4): 44 doi: 10.3390/scipharm86040044
|
| 31 |
Z A Kalmykova, I V Kononenko, A Yu Mayorov. Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis. Terapevticheskii arkhiv 2019; 91(10): 106 doi: 10.26442/00403660.2019.10.000165
|
| 32 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
|
| 33 |
Raymond Anthony Pashun, Nicole T. Shen, Arun Jesudian. Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C. Case Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/7807921
|
| 34 |
Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells 2019; 8(11): 1410 doi: 10.3390/cells8111410
|
| 35 |
Franziska Wolter, Andreas Glässner, Benjamin Krämer, Pavlos Kokordelis, Claudia Finnemann, Dominik J. Kaczmarek, Felix Goeser, Philipp Lutz, Hans Dieter Nischalke, Christian P. Strassburg, Ulrich Spengler, Jacob Nattermann. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection. Journal of Hepatology 2015; 63(6): 1334 doi: 10.1016/j.jhep.2015.08.008
|
| 36 |
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76135
|
| 37 |
Kara W. Chew, Chia-Ying Liu, Bharath Ambale-Venkatesh, Diana Liao, Tamara B. Horwich, João A.C. Lima, David A. Bluemke, J. Paul Finn, Adeel A. Butt, Judith S. Currier. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. Journal of International Medical Research 2017; 45(6): 1693 doi: 10.1177/0300060517708919
|
| 38 |
Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui. Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.826248
|
| 39 |
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Hepatitis C Virus II. 2016; : 109 doi: 10.1007/978-4-431-56101-9_4
|
| 40 |
Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Hui-Fang Yang, Chen-Jung Wu, Yu-Shan Sun, Wei-Liang Chen, Umberto Vespasiani-Gentilucci. Increased body fat percentage in patients with hepatitis B and C virus infection. PLOS ONE 2018; 13(7): e0200164 doi: 10.1371/journal.pone.0200164
|
| 41 |
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
|
| 42 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
|
| 43 |
Ayman Alsebaey, Mostafa Elhelbawy, Wael Abdel-Razek, Mohammed Hashim, Hassan Elshenawy, Imam Waked. HCV treatment with direct acting antivirals improves the insulin sensitivity. Expert Review of Anti-infective Therapy 2019; 17(9): 749 doi: 10.1080/14787210.2019.1653184
|
| 44 |
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0241-4
|
| 45 |
C. Schnier, S. Wild, Z. Kurdi, C. Povey, D. J. Goldberg, S. J. Hutchinson. Matched population‐based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection. Journal of Viral Hepatitis 2016; 23(8): 596 doi: 10.1111/jvh.12520
|
| 46 |
Ayman Alsebaey, Mostafa Elhelbawy, Imam Waked. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. European Journal of Gastroenterology & Hepatology 2018; 30(2): 207 doi: 10.1097/MEG.0000000000001013
|
| 47 |
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus. Revista de Gastroenterología de México (English Edition) 2020; 85(2): 173 doi: 10.1016/j.rgmxen.2019.05.007
|
| 48 |
Telma E. Silva, Marcelo F. Ronsoni, Leonardo L. Schiavon. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(3): 431 doi: 10.1016/j.dsx.2017.12.013
|
| 49 |
Marina Angel, Yelena Petrosyan, Mary-Anne Doyle, Curtis Cooper. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01198-x
|
| 50 |
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez. Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infectious Diseases and Therapy 2018; 7(4): 473 doi: 10.1007/s40121-018-0218-x
|
| 51 |
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri, Nicola Coppola. Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology 2020; 1323: 115 doi: 10.1007/5584_2020_604
|
| 52 |
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
|
| 53 |
Ratna B. Ray, Ranjit Ray. Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long‐Term Relationship. Hepatology 2019; 69(2): 889 doi: 10.1002/hep.30214
|
| 54 |
Nalan Okuroglu, Meltem Sertbas, Ali Ozdemir. Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes. Case Reports in Hepatology 2018; 2018: 1 doi: 10.1155/2018/5260510
|
| 55 |
Shimeng Xu, Xuelin Zhang, Pingsheng Liu. Lipid droplet proteins and metabolic diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(5): 1968 doi: 10.1016/j.bbadis.2017.07.019
|
| 56 |
Melania Gaggini, Fabrizia Carli, Chiara Rosso, Ramy Younes, Romina D’Aurizio, Elisabetta Bugianesi, Amalia Gastaldelli. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease. International Journal of Molecular Sciences 2019; 20(24): 6333 doi: 10.3390/ijms20246333
|
| 57 |
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Hepatic Oncology 2017; 4(3): 83 doi: 10.2217/hep-2017-0013
|
| 58 |
G. M. Jeenalieva. THE SIGNS OF CARBOHYDRATE-LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CHRONIC HEPATITIS C. Hepatology and Gastroenterology 2021; 5(1): 56 doi: 10.25298/2616-5546-2021-5-1-56-60
|
| 59 |
Chaoxing Li, Valentin Dinu. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma. Journal of Biomedical Informatics 2018; 81: 31 doi: 10.1016/j.jbi.2018.03.013
|
| 60 |
Ramesh Kumar, Diego García-Compeán, Tanmoy Maji. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World Journal of Hepatology 2022; 14(7): 1291-1306 doi: 10.4254/wjh.v14.i7.1291
|
| 61 |
Jhon Edison Prieto-Ortiz, Nathaly Garzón Orjuela, Santiago Sánchez-Pardo, Robin Germán Prieto-Ortíz, Javier Eslava Schmalbach. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva. Revista colombiana de Gastroenterología 2022; 37(1): 24 doi: 10.22516/25007440.703
|
| 62 |
Chien-Hao Huang, Lung-Sheng Wu, Wen-Juei Jeng, Yu-Fu Cheng, Yu-Shien Ko, I-Shyan Sheen, Chun-Yen Lin, Giuseppina Novo. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival. PLOS ONE 2019; 14(3): e0212770 doi: 10.1371/journal.pone.0212770
|
| 63 |
Mei-Yueh Lee, Wei-Chun Chen, Wei-Hao Hsu, Szu-Chia Chen, Jin-Ching Lee. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism. International Journal of Molecular Sciences 2019; 20(18): 4569 doi: 10.3390/ijms20184569
|
| 64 |
Mostafa Elhelbawy, Wael Abdel-Razek, Ayman Alsebaey, Mohamed Hashim, Hassan Elshenawy, Imam Waked. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment. European Journal of Gastroenterology & Hepatology 2019; 31(1): 16 doi: 10.1097/MEG.0000000000001215
|
| 65 |
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3567 doi: 10.2147/DMSO.S319895
|
| 66 |
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70721
|
| 67 |
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C. Annals of Hepatology 2017; 16(2): 215 doi: 10.5604/16652681.1231581
|
| 68 |
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Toshifumi Tada, Takanori Ito, Junko Tanaka. Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis. Journal of Viral Hepatitis 2021; 28(9): 1293 doi: 10.1111/jvh.13562
|
| 69 |
Alicia Oca�a‑Mondrag�n, Jos� Mata‑Mar�n, Mario Uriarte‑L�pez, Carolina Bekker‑M�ndez, Enrique Alcal�‑Mart�nez, Rosa Ribas‑Aparicio, Luis Uribe‑Nogu�z, Dulce Rodr�guez‑Galindo, Mar�a Mart�nez‑Rodr�guez. Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients. Biomedical Reports 2017; doi: 10.3892/br.2017.1012
|
| 70 |
Kiara Gonçalves Dias Diniz, Diego Alves Vieira, Enrico Antonio Colosimo, Marta Paula Pereira Coelho, Tatiana Bering, Rosangela Teixeira, Maria Isabel Toulson Davidson Correia, Gifone Aguiar Rocha, Luciana Diniz Silva. Derivation and validation of a simple anthropometric equation to predict fat-free mass in patients with chronic hepatitis C. Clinical Nutrition 2021; 40(3): 1281 doi: 10.1016/j.clnu.2020.08.011
|
| 71 |
Mashani Mohamad, Sarah Jayne Mitchell, Lindsay Edward Wu, Melanie Yvonne White, Stuart James Cordwell, John Mach, Samantha Marie Solon‐Biet, Dawn Boyer, Dawn Nines, Abhirup Das, Shi‐Yun Catherine Li, Alessandra Warren, Sarah Nicole Hilmer, Robin Fraser, David Andrew Sinclair, Stephen James Simpson, Rafael Cabo, David George Le Couteur, Victoria Carroll Cogger. Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age‐related insulin resistance. Aging Cell 2016; 15(4): 706 doi: 10.1111/acel.12481
|
| 72 |
Carlos Esteban Coronel-Castillo, Xingshun Qi, Jocelyn Contreras-Carmona, Oscar Lenin Ramírez-Pérez, Nahum Méndez-Sánchez. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Expert Review of Gastroenterology & Hepatology 2019; 13(6): 531 doi: 10.1080/17474124.2019.1599284
|
| 73 |
Keke Wu, Shuangqi Fan, Linke Zou, Feifan Zhao, Shengming Ma, Jindai Fan, Xiaowen Li, Mingqiu Zhao, Huichao Yan, Jinding Chen. Molecular Events Occurring in Lipophagy and Its Regulation in Flaviviridae Infection. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.651952
|
| 74 |
Victoria Green, Marina Roytman, Haruki Komatsu. Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review. Case Reports in Hepatology 2022; 2022: 1 doi: 10.1155/2022/3556780
|